A detailed history of Pictet Asset Management Holding Sa transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,195,779 shares of PLRX stock, worth $13.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,195,779
Previous 1,307,611 8.55%
Holding current value
$13.5 Million
Previous $19.5 Million 34.02%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.58 - $15.61 $1.18 Million - $1.75 Million
-111,832 Reduced 8.55%
1,195,779 $12.9 Million
Q1 2024

May 14, 2024

SELL
$14.14 - $19.59 $158,269 - $219,270
-11,193 Reduced 0.85%
1,307,611 $19.5 Million
Q4 2023

Feb 13, 2024

BUY
$12.85 - $19.15 $5.37 Million - $8 Million
417,514 Added 46.32%
1,318,804 $23.9 Million
Q3 2023

Nov 14, 2023

BUY
$14.58 - $20.15 $13.1 Million - $18.2 Million
901,290 New
901,290 $15.6 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $551M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.